SiRNA knockdown of the DEK nuclear protein mRNA enhances apoptosis and chemosensitivity of canine transitional cell carcinoma cells

The Veterinary Journal
Hiroki YamazakiSatoshi Takagi

Abstract

Transitional cell carcinoma (TCC) in dogs is an aggressive malignant neoplasm, originating in the epithelium of the urinary bladder. The DEK nuclear protein is overexpressed in several types of human bladder cancer, where it is involved in chromatin reconstruction, gene transcription and apoptosis. Since DEK represents a potential therapeutic target for canine TCC, this study was designed to investigate DEK expression in canine TCC and to determine the effects of DEK mRNA silencing on TCC cells in vitro. The gene expression profiles of seven selected cancer-associated genes was assessed in four canine TCC cell lines and expression of DEK protein was evaluated in bladder tissue biopsies from healthy dogs and those affected with cystitis or TCC. After transfection of four canine TCC cell lines with DEK-specific or scrambled siRNA, annexin V staining was performed to evaluate apoptosis, and methylthiazole tetrazolium assays were performed to assess both cell viability and sensitivity to carboplatin. DEK mRNA expression was relatively high in canine TCC cells and expression of the DEK protein was significantly greater in TCC tumours compared with the other tissue samples. After transfection with DEK-specific siRNA, apoptosis, cell ...Continue Reading

References

Feb 12, 1998·Journal of Veterinary Internal Medicine·R ChunC M Han
Apr 10, 2003·Journal of Veterinary Internal Medicine·Anthony J MutsaersDeborah W Knapp
Jul 11, 2003·The Veterinary Clinics of North America. Small Animal Practice·Philip J Bergman
Jul 24, 2003·The American Journal of Pathology·Marta Sanchez-CarbayoCarlos Cordon-Cardo
May 7, 2005·The Journal of Veterinary Medical Science·Satoshi TakagiToru Fujinaga
May 25, 2006·Cell Cycle·Maria Stella CarroHeiko Müller
Aug 9, 2006·Molecular and Cellular Biology·Trisha M Wise-DraperSusanne I Wells
Jan 31, 2009·Veterinary and Comparative Oncology·W Velando RankinJ A Green
Feb 21, 2009·Journal of Cellular Biochemistry·Dong-Wook KimSang-Beom Seo
Jun 1, 2005·Veterinary and Comparative Oncology·P A BoriaD W Knapp
Aug 15, 2009·Cancer Research·Michael S KhodadoustMaría S Soengas
Mar 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paola SecchieroGiorgio Zauli
May 1, 2010·The Journal of Veterinary Medical Science·Hirotaka TomiyasuHajime Tsujimoto
May 27, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Erica Riveiro-Falkenbach, María S Soengas
Jun 10, 2011·Nucleic Acids Research·Gina M KavanaughSusanne I Wells
Jun 15, 2011·BMC Cancer·Antara DattaJason P Trama

❮ Previous
Next ❯

Citations

Mar 21, 2017·Scientific Reports·Eric A SmithSusanne I Wells
Dec 15, 2018·Veterinary and Comparative Oncology·Tatsuya DeguchiMasahiro Okumura
Sep 25, 2018·Veterinary and Comparative Oncology·Kosei SakaiNaoaki Matsuki
Dec 12, 2020·Frontiers in Veterinary Science·Victoria Vitti GambimCarlos Eduardo Fonseca-Alves
Nov 1, 2021·Veterinary and Comparative Oncology·Koangyong SungMasahiro Okumura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis